Answers are grounded in this paper and cite their sources.
The pathway of ar-ketoglutarate catabolism in mammalian liver to glucose, fatty acids, and other products is generally considered to proceed in the mitochondria through the Krebs cycle to succinate.Thus, both ol-ketoglutarate-2-and -5-l4C would be expected to give carboxyl-labeled products.However, an examination of the enzymes of citric acid and isocitric acid metabolism, their subcellular localization, and their properties suggests that a-ketoglutarate can be catabolized by an alternate pathway in the cytoplasm.This pathway proceeds by the reductive carboxylation of a-ketoglutarate to isocitrate, the isomerization of isocitrate to citrate, and the cleavage of citrate to oxaloacetate and acetyl coenzyme A, and can be summarized as follows.a-Ketoglutarate + isocitrate -+ citrate + acetyl-CoA + oxaloacetateBecause citrate behaves asymmetrically during the cleavage reaction (2, 3), carbon atom 2 of ketoglutarate will be converted to the methylene carbon of oxaloacetate, whereas carbon atom 5 will appear in acetyl-CoA.Thus it would be anticipated that a-ketoglutarate-2-and -5-14C would produce distinctly different labeling patterns in products such as glucose and fatty acid derived from acetyl-CoA and oxaloacetate.This paper presents evidence for the existence of such a pathway in the isolated, perfused rat liver.EXPERIMENTAL PROCEDURE nL-Glutamic acid-2-and -5-14C, each with an approximate specific activity of 1.5 mc per mmole, were purchased from Nuclear Research Chemicals.In all experiments a tracer dose of 12.5 PC of the DL compound was used.Yields are referred to as percentages of the dose of L isomer, since it has been shown that n-glutamate is not utilized to any great extent by rat liver (4).
No takes yet. Share an insight, caveat, or question.
D’Adamo et al. (1965) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: